SAN FRANCISCO--(BUSINESS WIRE)--Propel(x), the online angel investment platform that helps investors source, evaluate, and fund pioneering science and technology startups, today announced that ...
Today marks the launch of the radiopharmaceutical company Fuzionaire Diagnostics (Dx). In light of the company launch, we spoke to Anton Toutov, Co-Founder and CSO at Fuzionaire, to learn how their ...
PET ligands play important roles in drug discovery relating to the central nervous system. However, the discovery efforts of PET ligands have suffered from high attrition rates due to a demanding list ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback